Based on the SHANG.FOS.PHARM.GR.H YC 1 stock forecast from 0 analysts, the average analyst target price for SHANG.FOS.PHARM.GR.H YC 1 is not available over the next 12 months. SHANG.FOS.PHARM.GR.H YC 1’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of SHANG.FOS.PHARM.GR.H YC 1 is Very Bullish, which is based on 2 positive signals and 0 negative signals. At the last closing, SHANG.FOS.PHARM.GR.H YC 1’s stock price was EUR 2.05. SHANG.FOS.PHARM.GR.H YC 1’s stock price has changed by -1.72% over the past week, -3.07% over the past month and 0% over the last year.
No recent analyst target price found for SHANG.FOS.PHARM.GR.H YC 1
No recent average analyst rating found for SHANG.FOS.PHARM.GR.H YC 1
Company Overview SHANG.FOS.PHARM.GR.H YC 1
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, anti-infection, API's and intermediate, metabolism, alimentary system, cardiovascular and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services, and investment management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China. Address: Read Less
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical D...Read More
N/A
N/A
38,591
December
EUR
Germany
Adjusted Closing Price for SHANG.FOS.PHARM.GR.H YC 1 (08HH:F)
Loading...
Unadjusted Closing Price for SHANG.FOS.PHARM.GR.H YC 1 (08HH:F)
Loading...
Share Trading Volume for SHANG.FOS.PHARM.GR.H YC 1 Shares
Loading...
Compare Performance of SHANG.FOS.PHARM.GR.H YC 1 Shares
Frequently Asked Questions About SHANG.FOS.PHARM.GR.H YC 1 (08HH:F) Stock
Stock Target Advisor's fundamental analysis for SHANG.FOS.PHARM.GR.H YC 1's stock is Very Bullish.
08HH:F stock's dividend yield is 2.61%.
Our analysis grades 08HH:F stock's dividend yield at D-. This means that 08HH:F stock's dividend yield
is above 61% of the stocks in the Drug Manufacturers-Specialty & Generic sector in the F exchange.
Based on this 08HH:F may be a average dividend stock for its sector.
Unfortunately we do not have enough data on 08HH:F's stock to indicate what its average analyst target is.
08HH:F stock's Price/Earning ratio is 11.04.
Our analysis grades 08HH:F stock's Price / Earning ratio at C-. This means that 08HH:F stock's Price/Earning ratio is above 29% of the stocks in the Drug Manufacturers-Specialty & Generic sector in the F exchange.
Based on this 08HH:F may be undervalued for its sector.
The last closing price of 08HH:F's stock was EUR 2.05.
The most recent market capitalization for 08HH:F is EUR 8.87B.
Unfortunately we do not have enough analyst data on 08HH:F's stock to indicate whether its price will go up or not.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
There is nothing we particularly dislike
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 08HH:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
